UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1764) 1764
science & technology (1709) 1709
life sciences & biomedicine (1638) 1638
male (1327) 1327
hiv infections - drug therapy (1248) 1248
female (1019) 1019
anti-hiv agents - therapeutic use (895) 895
benzoxazines - therapeutic use (888) 888
adult (819) 819
benzoxazines (786) 786
pharmacology & pharmacy (710) 710
infectious diseases (631) 631
reverse transcriptase inhibitors - therapeutic use (622) 622
animals (593) 593
efavirenz (548) 548
middle aged (505) 505
oxazines - therapeutic use (496) 496
hiv (457) 457
benzoxazines - pharmacology (451) 451
drug therapy, combination (412) 412
aids/hiv (351) 351
treatment outcome (350) 350
immunology (348) 348
benzoxazines - administration & dosage (341) 341
morpholines - pharmacology (337) 337
hiv infections - virology (335) 335
naphthalenes - pharmacology (335) 335
drug therapy (325) 325
viral load (323) 323
antiretroviral drugs (321) 321
human immunodeficiency virus--hiv (318) 318
rats (316) 316
anti-hiv agents - adverse effects (308) 308
benzoxazines - adverse effects (307) 307
cd4 lymphocyte count (294) 294
nevirapine - therapeutic use (293) 293
antiviral agents (284) 284
virology (281) 281
neurosciences (274) 274
hiv-1 - drug effects (270) 270
neurosciences & neurology (269) 269
anti-hiv agents - administration & dosage (252) 252
lamivudine - therapeutic use (238) 238
hiv infection (233) 233
antiretroviral therapy, highly active (227) 227
dose-response relationship, drug (220) 220
benzoxazines - pharmacokinetics (219) 219
reverse transcriptase inhibitors - adverse effects (214) 214
analysis (203) 203
hiv protease inhibitors - therapeutic use (199) 199
drug interactions (198) 198
microbiology (196) 196
hiv-1 (183) 183
highly active antiretroviral therapy (181) 181
antiretroviral therapy (180) 180
research (177) 177
mice (176) 176
adolescent (174) 174
young adult (173) 173
anti-hiv agents - pharmacokinetics (169) 169
tenofovir (167) 167
aged (165) 165
hiv-1 - genetics (162) 162
oxazines - adverse effects (162) 162
reverse transcriptase inhibitors - administration & dosage (162) 162
time factors (161) 161
hiv infections - complications (157) 157
adenine - analogs & derivatives (149) 149
ritonavir - therapeutic use (149) 149
rats, sprague-dawley (141) 141
virus diseases (141) 141
health aspects (140) 140
piperidines - pharmacology (140) 140
zidovudine - therapeutic use (140) 140
care and treatment (139) 139
pharmacology (139) 139
prospective studies (137) 137
abridged index medicus (136) 136
pyrazoles - pharmacology (135) 135
disease models, animal (133) 133
rna, viral - blood (133) 133
adenine - therapeutic use (132) 132
nevirapine (132) 132
aids (131) 131
dosage and administration (127) 127
cannabinoids - pharmacology (126) 126
hiv infections - immunology (125) 125
drug combinations (124) 124
cohort studies (123) 123
rats, wistar (123) 123
anti-hiv agents - pharmacology (119) 119
dideoxynucleosides - therapeutic use (119) 119
hiv infections - blood (119) 119
cannabinoids (118) 118
child (118) 118
reverse transcriptase inhibitors - pharmacokinetics (118) 118
drug administration schedule (117) 117
genotype (117) 117
oxazines - administration & dosage (116) 116
benzoxazines - blood (115) 115
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2218) 2218
French (25) 25
German (23) 23
Spanish (14) 14
Portuguese (10) 10
Chinese (5) 5
Dutch (4) 4
Italian (4) 4
Japanese (4) 4
Russian (3) 3
Czech (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
..., Co Cork, Ireland) is an NNRTI that has been approved for use in the USA. It is a potential alternative to efavirenz for treatment-naive patients infected... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 1019 - 1024
Journal Article
Tropical medicine & international health, ISSN 1360-2276, 07/2015, Volume 20, Issue 7, pp. 914 - 918
...) or TDF/3TC combined with efavirenz (EFV) or nevirapine (NVP). Patient characteristics and clinical/therapeutic history were collected on the day of blood draw for viral load (VL... 
Terapia Antirretroviral | zidovudine | tenofovir | nucleoside reverse transcriptase inhibitor | Africa | anti‐retroviral therapy | thérapie antirétrovirale | Inhibidor Nucleósido de la Transcriptasa Inversa | l'Afrique | África | viral load | HIV | VIH | charge virale | inhibiteur de la transcriptase inverse nucléosidique | Zidovudina | ténofovir | Carga Viral | Tenofovir | Anti-retroviral therapy | Nucleoside reverse transcriptase inhibitor | Viral load | Zidovudine | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | Tropical Medicine | Anti-HIV Agents - pharmacology | Humans | Middle Aged | Male | HIV - drug effects | Viral Load | Adenine - therapeutic use | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Health Resources | Lesotho | Adenine - analogs & derivatives | Cross-Sectional Studies | Organophosphonates - therapeutic use | HIV Infections - virology | Zidovudine - pharmacology | Logistic Models | Adenine - pharmacology | Benzoxazines - therapeutic use | Antiretroviral Therapy, Highly Active | Organophosphonates - pharmacology | HIV Infections - drug therapy | Zidovudine - therapeutic use | DNA polymerases | Analysis | Comparative studies | Antiretroviral drugs | Pharmacology | Drug therapy | Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 10/2008, Volume 198, Issue 8, pp. 1113 - 1122
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9692, pp. 796 - 806
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2006, Volume 354, Issue 3, pp. 251 - 260
Journal Article
Annals of internal medicine, ISSN 0003-4819, 01/2013, Volume 158, Issue 2, pp. 84 - 92
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article